AR122328A1 - TIM-3 INHIBITORS AND THEIR USES - Google Patents
TIM-3 INHIBITORS AND THEIR USESInfo
- Publication number
- AR122328A1 AR122328A1 ARP200102898A ARP200102898A AR122328A1 AR 122328 A1 AR122328 A1 AR 122328A1 AR P200102898 A ARP200102898 A AR P200102898A AR P200102898 A ARP200102898 A AR P200102898A AR 122328 A1 AR122328 A1 AR 122328A1
- Authority
- AR
- Argentina
- Prior art keywords
- tim
- inhibitors
- maintenance
- subject
- aml
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen terapias de mantenimiento que comprenden inhibidores de TIM-3. Las terapias de mantenimiento pueden usarse para tratar afecciones y trastornos cancerosos, que incluyen cánceres hematológicos. Además se divulgan las terapias de mantenimiento que comprenden inhibidores de TIM-3. Reivindicación 1: Una terapia de mantenimiento que comprende un inhibidor de TIM-3 para el uso en el tratamiento de una leucemia mieloide agua (AML) en un sujeto. Reivindicación 2: Un método de tratamiento de una leucemia mieloide agua (AML) en un sujeto, que comprende administrar al sujeto una cantidad eficaz de una terapia de mantenimiento que comprende un inhibidor de TIM-3, de manera de tratar la AML.Maintenance therapies comprising inhibitors of TIM-3 are described. Maintenance therapies can be used to treat cancerous conditions and disorders, including hematologic cancers. Furthermore, maintenance therapies comprising TIM-3 inhibitors are disclosed. Claim 1: A maintenance therapy comprising a TIM-3 inhibitor for use in treating acute myeloid leukemia (AML) in a subject. Claim 2: A method of treating acute myeloid leukemia (AML) in a subject, comprising administering to the subject an effective amount of a maintenance therapy comprising a TIM-3 inhibitor, so as to treat AML.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962923928P | 2019-10-21 | 2019-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR122328A1 true AR122328A1 (en) | 2022-08-31 |
Family
ID=83218740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP200102898A AR122328A1 (en) | 2019-10-21 | 2020-10-20 | TIM-3 INHIBITORS AND THEIR USES |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR122328A1 (en) |
-
2020
- 2020-10-20 AR ARP200102898A patent/AR122328A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR126205A2 (en) | METHODS OF USE OF TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE REFRACTORY MELANOMA | |
PH12017500070A1 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
AR044007A1 (en) | METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
MX2020009773A (en) | Combination therapy. | |
AU2018341571A8 (en) | Therapeutic methods relating to HSP90 inhibitors | |
MX2020008906A (en) | Compounds with ferroptosis inducing activity and methods of their use. | |
CO2020013600A2 (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
UY28287A1 (en) | COMBINATIONS FOR THE TREATMENT OF DISEASES THAT IMPACT CELLULAR PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS | |
BR112022016382A2 (en) | SPECIFIC TRIPTAMINES FOR USE IN THE TREATMENT OF MOOD DISEASES | |
MX2020013163A (en) | Methods of treating malignant lymphoproliferative disorders. | |
MX2021010173A (en) | Compounds with ferroptosis inducing activity and methods of their use. | |
MX2019009227A (en) | Methods for treating cancer using hsp90 inhibitors. | |
MX2020001727A (en) | Combination therapy. | |
BR112021020409A2 (en) | Combination therapy with anti-bcma antibody and gamma-secretase inhibitor | |
BR112015026247A2 (en) | methods for cancer treatment using tor kinase inhibitor combination therapy | |
WO2018102687A3 (en) | Combination therapy for treating cancer | |
MX2019013862A (en) | Combination therapy. | |
MX2020008680A (en) | Combination therapy with apilimod and glutamatergic agents. | |
CL2022001878A1 (en) | Combination comprising a thym-3 inhibitor and a hypomethylating agent for use in the | |
CL2023002223A1 (en) | CDK2 inhibitors and methods of their use | |
BR112022007179A2 (en) | TIM-3 INHIBITORS AND USES THEREOF | |
MX2021007330A (en) | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor. | |
MX2021007565A (en) | Compositions and methods for cancer therapy. | |
DOP2021000215A (en) | HEADACHE TREATMENT USING ANTI-CGRP ANTIBODY | |
EA202193276A1 (en) | METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA |